查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386264

闌尾炎診斷與治療市場報告：2030 年趨勢、預測與競爭分析

Appendicitis Diagnostics and Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

闌尾炎診斷和治療的趨勢和預測

2030年，全球闌尾炎診斷和治療市場預計將達到140億美元，2024年至2030年年複合成長率為7.1%。該市場的主要促進因素是闌尾炎和兒童闌尾炎盛行率的不斷上升、人們對闌尾炎的認知不斷增強以及全球整體醫療保健支出的增加。全球闌尾炎診斷和治療市場的未來前景廣闊，醫院、診所和診斷影像中心市場充滿商機。

闌尾炎診斷和治療市場洞察

急性闌尾炎的特徵是闌尾發炎在數小時至數天內快速發作，Lucintel 預測在預測期內將出現高成長。

醫院和診所可能仍然是市場中最大的部分。

由於闌尾炎的高發病率以及人們對該疾病的認知不斷提高，北美在預測期內可能仍然是最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2. 未來哪個細分市場成長較快？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球闌尾炎診療市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球闌尾炎診斷和治療市場趨勢（2018-2023）和預測（2024-2030）
  • 按類型分類的全球闌尾炎診斷和治療市場
    • 急性
    • 慢性的
  • 按診斷治療分類的全球闌尾炎診斷與治療市場
    • 診斷
    • 治療
  • 按最終用途分類的全球闌尾炎診斷和治療市場
    • 醫院
    • 診所
    • 影像診斷中心

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球闌尾炎診斷和治療市場（按地區）
  • 北美闌尾炎診斷與治療市場
  • 歐洲闌尾炎診斷與治療市場
  • 亞太地區闌尾炎診斷與治療市場
  • 其他區域性闌尾炎診療市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球闌尾炎診斷和治療市場成長機會（按類型）
    • 全球闌尾炎診斷和治療市場診斷治療的成長機會
    • 全球闌尾炎診斷和治療市場成長機會（按最終用途）
    • 全球闌尾炎診斷和治療市場按地區成長機會
  • 全球闌尾炎診斷和治療市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球闌尾炎診斷和治療市場的能力
    • 全球闌尾炎診斷和治療市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Johnshon & Johnshon
  • Pfizer
  • Lupin
  • Siemens
  • Medtronic
  • Cook
  • Teva Pharmaceutical industries
簡介目錄

Appendicitis Diagnostics and Treatment Trends and Forecast

The future of the global appendicitis diagnostics and treatment market looks promising with opportunities in the hospital, clinic, and diagnostic imaging center markets. The global appendicitis diagnostics and treatment market is expected to reach an estimated $14 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of appendicitis and pediatric appendicitis, growing awareness towards appendicitis, and rising healthcare spending across the globe.

A more than 150-page report is developed to help in your business decisions.

Appendicitis Diagnostics and Treatment by Segment

The study includes a forecast for the global appendicitis diagnostics and treatment by type, diagnosis treatment, end use, and region.

Appendicitis Diagnostics and Treatment Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Acute
  • Chronic

Appendicitis Diagnostics and Treatment Market by Diagnosis Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnosis
  • Treatment

Appendicitis Diagnostics and Treatment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Diagnostic Imaging Centers

Appendicitis Diagnostics and Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Appendicitis Diagnostics and Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies appendicitis diagnostics and treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the appendicitis diagnostics and treatment companies profiled in this report include-

  • Johnshon & Johnshon
  • Pfizer
  • Lupin
  • Siemens
  • Medtronic
  • Cook
  • Teva Pharmaceutical Industries

Appendicitis Diagnostics and Treatment Market Insights

Lucintel forecasts that acute appendicitis is expected to witness higher growth over the forecast period as it is characterized by inflammation of the appendix that develops rapidly, over a period of hours or days.

Within this market, hospitals & clinics will remain the largest segment.

North America will remain the largest region over the forecast period due to high prevalence of appendicitis and increasing awareness of the disease among people.

Features of the Global Appendicitis Diagnostics and Treatment Market

Market Size Estimates: Appendicitis diagnostics and treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Appendicitis diagnostics and treatment market size by type, diagnosis treatment, end use, and region in terms of value ($B).

Regional Analysis: Appendicitis diagnostics and treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, diagnosis treatments, end uses, and regions for the appendicitis diagnostics and treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the appendicitis diagnostics and treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the appendicitis diagnostics and treatment market size?

Answer: The global appendicitis diagnostics and treatment market is expected to reach an estimated $14 billion by 2030.

Q.2 What is the growth forecast for appendicitis diagnostics and treatment market?

Answer: The global appendicitis diagnostics and treatment market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the appendicitis diagnostics and treatment market?

Answer: The major drivers for this market are increasing prevalence of appendicitis and pediatric appendicitis, growing awareness towards appendicitis, and rising healthcare spending across the globe.

Q4. What are the major segments for appendicitis diagnostics and treatment market?

Answer: The future of the appendicitis diagnostics and treatment market looks promising with opportunities in the hospital, clinic, and diagnostic imaging center markets.

Q5. Who are the key appendicitis diagnostics and treatment market companies?

Answer: Some of the key appendicitis diagnostics and treatment companies are as follows:

  • Johnshon & Johnshon
  • Pfizer
  • Lupin
  • Siemens
  • Medtronic
  • Cook
  • Teva Pharmaceutical Industries

Q6. Which appendicitis diagnostics and treatment market segment will be the largest in future?

Answer: Lucintel forecasts that acute appendicitis is expected to witness higher growth over the forecast period as it is characterized by inflammation of the appendix that develops rapidly, over a period of hours or days.

Q7. In appendicitis diagnostics and treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high prevalence of appendicitis and increasing awareness of the disease among people.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the appendicitis diagnostics and treatment market by type (acute and chronic), diagnosis treatment (diagnosis and treatment), end use (hospitals, clinics, and diagnostic imaging centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Appendicitis Diagnostics and Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Appendicitis Diagnostics and Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Appendicitis Diagnostics and Treatment Market by Type
    • 3.3.1: Acute
    • 3.3.2: Chronic
  • 3.4: Global Appendicitis Diagnostics and Treatment Market by Diagnosis Treatment
    • 3.4.1: Diagnosis
    • 3.4.2: Treatment
  • 3.5: Global Appendicitis Diagnostics and Treatment Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Clinics
    • 3.5.3: Diagnostic Imaging Centers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Appendicitis Diagnostics and Treatment Market by Region
  • 4.2: North American Appendicitis Diagnostics and Treatment Market
    • 4.2.2: North American Appendicitis Diagnostics and Treatment Market by End Use: Hospitals, Clinics, and Diagnostic Imaging Centers
  • 4.3: European Appendicitis Diagnostics and Treatment Market
    • 4.3.1: European Appendicitis Diagnostics and Treatment Market by Type: Acute and Chronic
    • 4.3.2: European Appendicitis Diagnostics and Treatment Market by End Use: Hospitals, Clinics, and Diagnostic Imaging Centers
  • 4.4: APAC Appendicitis Diagnostics and Treatment Market
    • 4.4.1: APAC Appendicitis Diagnostics and Treatment Market by Type: Acute and Chronic
    • 4.4.2: APAC Appendicitis Diagnostics and Treatment Market by End Use: Hospitals, Clinics, and Diagnostic Imaging Centers
  • 4.5: ROW Appendicitis Diagnostics and Treatment Market
    • 4.5.1: ROW Appendicitis Diagnostics and Treatment Market by Type: Acute and Chronic
    • 4.5.2: ROW Appendicitis Diagnostics and Treatment Market by End Use: Hospitals, Clinics, and Diagnostic Imaging Centers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Appendicitis Diagnostics and Treatment Market by Type
    • 6.1.2: Growth Opportunities for the Global Appendicitis Diagnostics and Treatment Market by Diagnosis Treatment
    • 6.1.3: Growth Opportunities for the Global Appendicitis Diagnostics and Treatment Market by End Use
    • 6.1.4: Growth Opportunities for the Global Appendicitis Diagnostics and Treatment Market by Region
  • 6.2: Emerging Trends in the Global Appendicitis Diagnostics and Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Appendicitis Diagnostics and Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Appendicitis Diagnostics and Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Johnshon & Johnshon
  • 7.2: Pfizer
  • 7.3: Lupin
  • 7.4: Siemens
  • 7.5: Medtronic
  • 7.6: Cook
  • 7.7: Teva Pharmaceutical industries